"Latest Medical News, Clinical Trials, Guidelines - Today on Medscape"
Wegovy recently also gained approval for the treatment of fatty liver disease (technically called metabolic dysfunction-associated steatohepatitis or MASH) in adults with moderate to advanced liver fibrosis
We all have experienced that loss of appetite during stressful situations when the thought of eating food just doesnt cross the mind
Expansion in obesity management, oral GLP-1 formulations, emerging market penetration, next-generation dual-agonists, and digital health integration offer significant growth opportunities
It seems people are more comfortable saying they microdose GLP-1s because it signals theyre not taking the drug for vanitys sake
Exercise Regularly Regular physical activityboth aerobic and resistance trainingnaturally boosts GLP-1 production